e-learning
resources
European Respiratory Review
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Modulator treatment for people with cystic fibrosis: moving in the right direction
J. Stuart Elborn
Source:
Eur Respir Rev, 29 (155) 200051; 10.1183/16000617.0051-2020
Journal Issue:
March
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Stuart Elborn. Modulator treatment for people with cystic fibrosis: moving in the right direction. Eur Respir Rev, 29 (155) 200051; 10.1183/16000617.0051-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Tezacaftor-ivacaftor for the treatment of cystic fibrosis: what’s next?
Source: International Congress 2018 – Therapeutic breakthroughs Year in Review
Year: 2018
Combination therapy in idiopathic pulmonary fibrosis: the way ahead will be hard
Source: Eur Respir J 2015; 45: 1208-1210
Year: 2015
Can step be a maximal test in children with cystic fibrosis?
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009
Does this patient have cystic fibrosis?
Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session
Year: 2017
Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward
Source: Eur Respir J 2013; 42: 1446-1448
Year: 2013
Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash?
Source: Eur Respir J 2011; 37: 757-759
Year: 2011
Treatment of right heart failure on pulmonary arterial hypertension: is going left a step in the right direction?
Source: Eur Respir Rev 2009; 19: 4-6
Year: 2010
Lung inflammation in cystic fibrosis: an overlooked therapeutic target?
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020
The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021
Year: 2021
Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end
Source: Eur Respir J, 52 (6) 1802111; 10.1183/13993003.02111-2018
Year: 2018
High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Cystic fibrosis patients: do they profit from altitiude residence?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006
The therapy of idiopathic pulmonary fibrosis: what is next?
Source: Eur Respir Rev, 28 (153) 190021; 10.1183/16000617.0021-2019
Year: 2019
Monitoring early lung disease in cystic fibrosis: where are we now?
Source: Breathe 2014; 10: 34-47
Year: 2014
A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021
Evaluation of a novel chest wall motion analysis system in cystic fibrosis and healthy volunteers
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Idiopathic pulmonary fibrosis: time for greater expectations?
Source: Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018
Year: 2018
Patient centred research: a model for involving cystic fibrosis (CF) patients in research planning
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept